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Abstract. Emerging evidence has shown that the tumor 
microenvironment plays a crucial role in prostate cancer (PCa) 
development and progression. However, the mechanism(s) 
through which stromal cells regulate epithelial cells and the 
differences among prostatic stromal cells of different histo-
logical/pathological origin in PCa progression remain unclear. 
Therefore, it is necessary to characterize the stromal cell 
populations present in benign prostatic hyperplasia (BPH) and 
PCa. To this end, we used cultures from stromal cells obtained 
from BPH-derived (15 cases) and PCa-derived (30 cases) 
primary cultures. In culture, stromal cells are a mixture of 
fibroblasts, myofibroblasts (MFs) and muscle cells. Fibroblasts 
are characterized for the expression of vimentin, MFs for 
the co-expression of α-smooth muscle actin (α-SMA) and 
vimentin, whereas muscle cells for the expression of α-SMA 
and desmin. Fibroblasts were present in large amounts in the 
BPH- compared to the PCa-derived cultures, whereas MFs 
were more representative of PCa- as opposed to BPH-derived 
cultures. Some α-SMA-positive cells retained the expression 
of basal cytokeratin K14. This population was defined as 
myoepithelial cells and was associated with senescent cultures. 
The percentage of MFs was higher in high-grade compared 
to moderate- and low-grade PCa-derived cultures, whereas 
the number of myoepithelial cells was lower in high-grade 
compared to moderate- and low-grade PCa-derived cultures. 
In addition, we analyzed the expression of p75NTR, as well as 
the expression of matrix metalloproteinase (MMP)-2, MMP-9 
and tissue inhibitors of MMPs (TIMPs). p75NTR expres-
sion was elevated in the stromal cultures derived from PCa 
compared to those derived from BPH and in cultures derived 
from cases with Gleason scores ≥7 compared to those derived 
from cases with Gleason scores <7, as well as in cultures 
with a high concentration of MFs compared to those with a 
high concentration of fibroblasts. MMP-2 was secreted by all 
primary cultures, whereas MMP-9 secretion was observed 
only in some PCa-derived stromal cells, when the percentage 
of MFs was significantly higher compared to BPH-derived 
cultures. TIMP1, TIMP2 and TIMP3 were secreted in elevated 
amounts in the BPH- compared to the PCa-derived stromal 
cultures, suggesting the differential regulation of extracellular 
matrix (ECM) degradation. When we used 22rv1 and PC3 
PCa xenograft models for the isolation and characterization of 
murine cancer-associated fibroblasts (CAFs) we noted that the 
angiogenic wave was concurrent with the appearance of a reac-
tive stroma phenotype, as determined by staining for α-SMA, 
vimentin, tenascin, calponin, desmin and Masson's trichrome. 
In conclusion, MF stromal cells from PCa participate in the 
progression and metastasis of PCa, modualting inflammation, 
angiogenesis and epithelial cancer cell proliferation.
Introduction
The study of prostate carcinogenesis and tumor progression is 
difficult due to the lack of appropriate in vitro and in vivo models. 
Emerging evidence has shown that the tumor microenviron-
ment plays a crucial role in prostate cancer (PCa) development/
progression (1-4). Specifically, it has been observed that in PCa 
three disparate cellular outcomes predominate: i) the tumor 
remains well differentiated and clinically indolent; in this case 
the local stromal cells may act to restrain the growth of the 
cancer; ii) early in its genesis the tumor acquires a highly malig-
nant phenotype, growing rapidly and displacing the original 
stromal population (often referred to as small-cell PCa); these 
less common aggressive tumors are relatively independent of 
the local microenvironment; and iii) the tumor co-opts the local 
stroma, taking on a classic stromagenic phenotype where inter-
actions with the local microenvironment are critical to cancer 
growth. Therefore, tumor stromal cells can support tumor 
epithelial cell growth through the secretion of paracrine growth 
factors and/or providing a more favorable micro environment 
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for tumor growth. The stroma can elicit instructive, permissive, 
or inductive (reactive) effects on the parenchymal epithelium. 
For example, embryonic mesenchymal cells can ‘instruct’ 
epithelial cells to form functional, differentiated glands. By 
contrast, a ‘permissive’ stroma supports a previously-induced 
epithelial phenotype (5-8).
Molecular markers of stromal cell subpopulations have been 
poorly defined. Generally, fibroblasts are identified by their 
spindle-shaped morphology and the overlapping expression of 
various ‘indicators’ such as vimentin. Stroma cells are androgen 
receptor (AR)-negative. However, some cells retain the expres-
sion of AR (9,10). Stromal AR regulates epithelial proliferation, 
extracellular matrix (ECM) remodelling, neovasculature forma-
tion and immune cell infiltration through the secretion of 
pro-inflammatory cytokines/chemokines, whereas the loss 
of stromal AR leads to suppressed prostate tumorigenesis 
(9,11). Transforming growth factor-β (TGF-β) is a growth 
factor abundantly present in the stroma. This can induce or 
suppress differentiation and tumorigenesis in a dose- and 
context-dependant manner (4). Loss of the TGF-β type II 
receptor (TGFβR2) has been observed in the stroma of >60% 
of human PCa patients (12). Neurotrophin growth factor 
[nerve growth factor (NGF), brain-derived neurotrophic 
factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin-4/5 
(NT-4/5)] binding activates tyrosine kinase receptors 
encoded by the Trk family (Trk A, Trk B and Trk C), and 
the low-affinity receptor p75NTR. In the normal prostate, 
p75NTR and Trk A are found on benign prostate epithelial 
cells, whereas NGF-β is expressed by adjacent stromal cells 
(13-16). NGF-β stimulates the growth of prostate epithelial 
cells, which suggests the paracrine regulation of prostate 
cell growth by NGF-β or other neurotrophins. In contrast 
to benign prostate epithelial cells, p75NTR expression is 
decreased in cancer cells (13,14). A dramatic increase in p75 
immunoreactivity has been observed in the stroma and this 
correlates with an increase in malignancy (16).
To better clarify the cellular interactions mediated by the 
reactive stroma, we characterized the stromal cell population 
present in benign prostatic hyperplasia (BPH) and PCa using 
a previously described method (17,18). To this end, we evalu-
ated the expression of vimentin (in fibroblasts), vimentin and 
α-smooth muscle actin [α-SMA; in myofibroblasts (MFs)] 
or desmin (in muscle), as well as the expression of p75NTR, 
matrix metalloproteinase (MMP)-2 and MMP-9 and their 
tissue inhibitors (TIMPs). Stromal cells are a mixture of fibro-
blasts and MFs (19,20). The number of fibroblasts was higher in 
BPH- compared to PCa-derived cultures, whereas the number 
of MFs was higher in PCa- compared to BPH-derived cultures. 
The percentage MFs was higher in high-grade PCa-derived 
cultures compared to moderate- and low-grade PCa-derived 
cultures. p75NTR expression was also elevated in stromal cell 
cultures derived from PCa compared to those derived from 
BPH and in cultures derived from cases with Gleason scores ≥7 
compared to those derived from cases with Gleason scores <7, 
as well as in cultures with a high concentration of MFs 
(vimentin/α-SMA/desmin-positive) compared to cultures with 
a high concentration of fibroblasts. The present study confirms 
a novel, malignant-dependent localization of p75 in smooth 
muscle cells SMCs/MFs in stromal cell cultures derived from 
human PCa. Therefore, p75 re-expression in stromal SMCs/
MFs is a mechanism related to the general dedifferentiation of 
the stroma connected to neoplastic invasion.
Materials and methods
Reagents. All materials for tissue culture were purchased from 
HyClone (Cramlington, NE, USA). Plasticware was obtained 
from Nunc (Roskilde, Denmark). Antibodies, when not defined 
otherwise, were purchased from Santa Cruz Biotechnology, 
Inc. (Santa Cruz, CA, USA). Elisa kits for TGF-β1 and stromal 
cell-derived factor α (SDF1α) were purchased from RayBiotech 
(European distributor, Hölzel Diagnostika GmbH, Köln, 
Germany).
Stromal cell cultures from prostatic specimens. Tissue samples 
were collected by radical prostatectomy from patients attending 
the Urology Division of San Salvatore Hopital, L'Aquila, Italy. 
Our Institutional review board approved the protocol and 
a written informed consent was obtained from all human 
subjects. The tissue samples were enzymatically digested with 
collagenase type I (225 U/ml; Sigma, St. Louis, MA, USA) and 
hyaluronidase (125 U/ml; Sigma) in DMEM (with 10% FCS) at 
37˚C overnight. The supernatant containing the stromal cells 
was centrifuged at 250 x g for 5 min. The pellet was resus-
pended and plated in complete DMEM. After allowing the cells 
to grow to confluence, they were briefly trypsinized to release 
the stromal cells, which were then removed and expanded in 
DMEM with 5% FCS. After five passages, a homogeneous 
stromal cell population was established. Microscopy and 
immunocytochemistry were used to determine the purity of 
the stromal cell fraction. Epithelial cell exclusion assay was 
performed using a panel of different antibodies purchased from 
Sigma, when not specified. In particular, we used an anti-PAN 
cytokeratin antibody to evaluate the epithelial presence, anti-
K18, clone CY90, anti-K8 and clone M20 to evaluate luminar 
cells and anti-K14, clone CKB1 and anti-K5 (N20) polyclonal 
antibody to reco gnize basal cells. Anti-desmin polyclonal anti-
body was used to determine smooth muscle cell presence. Anti 
α-SMA, clone 1A4, anti-vimentin and clone V9, were used to 
determine the desmin-negative MF and fibroblast cell popu-
lations. Cells were counted and expressed as a percentage of 
vimentin-positive cells per microscopic field at x200 magnifi-
cation. Five separate fields were considered and the percentage 
of positive cells was expressed as the mean ± SE.
Western blot analysis. Cells were grown to confluence in 
100-mm dishes. The medium was then removed and the cells 
were washed with cold PBS and immediately lysed with 
1 ml of lysis buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 
10% glycerol, 1% Triton X-100, 1 mM EDTA, 1 mM EGTA, 
50 mM NaF, 30 mM p-nitrophenyl phosphate, 10 mM sodium 
pyrophosphate, 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml 
aprotinin and 10 µg/ml leupeptin). Lysates were centrifuged at 
10,000 x g for 10 min. Equal amounts of protein (50 µg) were 
resolved using 7.5% SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE). After electrophoresis, separated proteins were 
blotted onto a nitrocellulose membrane and analyzed by western 
blot analysis with the ECL method. Proteins were transferred 
from the gel onto a nitrocellulose filter paper. The membrane 
was washed with saline solution (Tris-HCl, NaCl and BSA at 
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1%) for 1 h and then incubated with different antibodies diluted 
at 1 µg/ml. After incubation the membrane was washed with 
Tris-NaCl plus 0.1% Tween-20 and incubated for 1 h with a 
second antibody conjugated with peroxidase (1:5,000). Protein 
bands were quantified by densitometry. Immunoreactive bands 
were visualized using enhanced chemiluminescence detection 
kit reagents (Amersham, Milan, Italy).
Gelatin zymography. The zymography assay (21) used gelatin 
as a substrate for MMP-2 and MMP-9. Gelatin at a concen-
tration of 0.1% was incorporated into a 10% polyacrylamide 
gel containing 0.4% SDS. Electrophoresis under non-reducing 
conditions was performed using the Bio-Rad mini-gel system 
at 125 V for 90-120 min. For plasminogen activator analysis, 
SDS-polyacrilamide gels were polymerized with 0.1 mg/ml 
of lactose-free casein and 15 µg/ml of human plasminogen as 
previously described (22). After electrophoresis the gels were 
washed twice for 30 min in 2.5% Triton X-100 (v/v) to remove 
the SDS and then incubated overnight in the developing buffer 
[50 mM Tris-HCl (pH 7.6), 200 mM NaCl, 5 mM CaCl2, 0.2% 
(v/v) Brij-35] at 37˚C. Digestion bands were quantified by the 
Java image processing program ‘ImageJ’ from the scanned 
gels. Reverse zymography for TIMPs was performed in 
concentrated supernatants containing 20 µg of proteins [condi-
tioned medium concentrated 20-fold by Centricon (Amicon, 
Beverly, MA, USA) with 10 kDa molecular weight cut-off] 
analyzed by 14% SDS-PAGE containing 0.1 casein and 30% 
(v/v) serum-free supernatants from the MDA-MB-231 human 
breast cancer cell line. This cell line expresses a single 53 kDa 
band of EDTA-inhibitable caseinolytic activity in zymograms 
(MMP-3). Gels were processed as described above except for 
a 72-h incubation in collagenase buffer. Dark stained bands of 
28-25 and 21 kDa molecular weight were identified as inhibitor 
bands of TIMP1/TIMP3 and TIMP2, respectively.
Statistics. The data are expressed as the mean and standard 
deviation (SD) and were compared using an unpaired Student's 
t-test. Categorical data were analyzed by the exact Fisher's 
test. A p-value <0.05 was considered to indicate a statistically 
significant difference.
Results
We characterized a total of 45 primary cultures derived from 
clinical samples, which, after the completion of the clinical 
work-up for each patient, were grouped according to the patho-
logical diagnosis formulated through the microscopic analysis 
of the biopsies obtained in parallel with cultured tissue samples. 
We studied in primary culture 15 cases of BPH and 30 cases of 
PCa of various pathological grades.
Stromal cell characterization. Primary cell culture was charac-
terized at each passage and a gradual decrease in the number of 
rounded cells with epithelial appearance and an increase in the 
number of elongated cells with fibroblastic aspects was observed, 
as demonstrated by the phase contrast micrographs (Fig. 1). In 
previous studies, it has been demonstrated that prostatic stromal 
cells are characterized by an increase in the expression of 
cytoskeleton proteins, such as vimentin and α-SMA, followed 
by a decrease in muscle markers, such as desmin (23,24). After 
five passages in our culture system, a cell population positively 
expressing vimentin and α-SMA, but negatively expressing cyto-
keratin 18 and weakly expressing desmin was obtained. These 
results indicate that our human pluripotent stem cell populations 
represent a combination of fibroblasts (vimentin-positive cells) 
and MFs (α-SMA-positive cells). Fig. 2 demonstrates the expres-
sion of cytoskeleton markers (α-SMA, vimentin and desmin) 
by western blot analysis. Fig. 3 demonstrates the expression of 
stromal markers, thymidine phosphorylase (TP), as well as that 
of the prostate markers, AR and prostate-specific antigen (PSA), 
or caveolin-1 and tenascin C as shown by western blot analysis 
in different cultures derived from BPH and PCa samples. The 
amount of these markers was quantified densitometrically as 
arbitrary densitometric units (ADUs) after normalization with 
Figure 1. Phase contrast photomicrograph of stromal cell cutlures. (A-F) x200 images. (A-C) Visible fibroblastic-like cells at different densities of growth ; 
(D-F) elongated cells with a final tendency to form fused cells (arrows, D and F) with several bright cytoplasmic organelles (arrows, E). The cells resemble 
myoepithelial/myofibroblast cells.
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β-actin. Vimentin expression was not statistically different in 
the BPH- compared to the PCa-derived cultures, both as the 
percentage of positve cells and adjusted densitometric units. 
Although the percentage of α-SMA-positive cells (Fig. 2B, C 
and G) was not statistically significant, the protein levels were 
significantly higher in the PCa - compared to the BPH-derived 
cultures (p<0.001, Fig. 2A, D and H). Similar results were 
obtained with desmin; although the percentage of desmin-
positive cells (Fig. 2B, C and G) was not statistically significant, 
the protein levels were significantly higher in PCa- compared 
to BPH-derived cultures. Desmin expression was weakly and 
mainly associated with PCa stromal cultures (p<0.001, Fig. 2A, 
Figure 2. Western blot analyses of stromal cell markers, vimentin, desmin and α-muscle actin (α-SMA), in primary culture cell extracts. (A) Representative 
BPH-derived 10 cultures. (B) Percentage of vimentin (VMTN)-, desmin- and α-SMA-positive cells in BPH-derived 10 cultures analyzed by western blot 
analysis. (C) Mean percentage of VMTN, α-SMA and desmin in the total 15 cases of BPH. (D) Adjusted densitometric units obtained after normalization to 
actin levels of immunoreactive bands in western blot analysis in the 15 BPH-derived cultures. (E) Representative PCa-derived 12 cultures. (F) Percentage of 
VMTN-, desmin- and α-SMA-positive cells in BPH-derived 12 cultures analyzed by western blot analysis. (G) Adjusted densitometric units obtained after 
normalization to actin levels of immunoreactive bands in western blot analysis in the 30 PCa-derived cultures. (H) Mean percentage of VMTN, α-SMA and 
desmin in the 30 cases of PCa. Each lane was loaded with 40 µg of total protein. 
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D and H). Although the number of samples was limited, 
we aimed to determine the correlation between the stromal 
cell population and histological grade (Gleason grade) in our 
samples. No statistically significant differences were observed 
for vimentin expression [2.1±1.0 (G2-4) ADU vs. 2.7±1.5 (G5-7) 
ADU and 4.3±1.8 (G8-10) ADU] and for α-SMA expression 
[4.7±1.2 (G2-4) ADU vs. 4.9±1.7 (G5-7) ADU and 5.7±2.1 
(G8-10) ADU]. Desmin expression was significantly lower in 
cultures derived from cases with a low Gleason grade compared 
to those derived from cases with a high Gleason grade [0.4±0.2 
(G2-4) ADU vs. 1.3±0.4 (G5-7) ADU and 2.4±0.6 in (G8-10), 
p<0.01]. The expression of K14 was observed in some stromal 
primary cultures and was restricted to PCa- compared to 
BPH-derived cultures (immuno-reactive bands for K14 were 
found in 1/15 BPH and 12/30 PCa cases; not significant) and 
in high-grade compared to moderate- and low-grade samples 
[1/7 (14.3%, G2-4), 5/15 (33.3%, G5-7) and 6/8 (75%, G8-10), 
p=0.043].
The levels of tenascin C verified by western blot analysis 
using the Santa Cruz Biotechnology (Scbt) antibody, N19, 
were significantly higher in cultures derived from PCa 
samples [1.2±0.9 ADU (mean ± SD) and 4.8±0.8 for BPH- and 
Ca-derived cultures, respectively, p<0.001] and in high-grade 
compared to moderate- and low-grade samples [3.2±0.4 (G2-4), 
3.9±0.1 (G5-7) and 6.0±1 (G8-10), p<0.001].
The AR (Scbt N20) is expressed in a subset of prostatic 
stromal cells and functional stromal cell AR is required for 
normal prostate development and influences the growth of 
prostate tumors. Fibroblasts are negative for AR, whereas MFs 
express AR. We observed that AR expression was present 
only in some PCa-derived cultures (17/30, 56.7%, vs. 5/15, 
33.3%, in PCa- and BPH-derived cultures, respectively) and 
in high-grade compared to moderate- and low-grade samples 
[3/10 (G2-4, 30%) vs. 7/15 (G5-7, 40%) and 7/8 (G8-10, 87.5%), 
p<0.005]. PSA secretion (Scbt A67-B/E3) was extremely 
low/absent in BPH- and PCa-derived cultures. The levels of 
p75NTR were significantly higher in PCa-derived (2.5±2.0 
ADU) compared with BPH-derived cultures (0.8±0.7 ADU, 
p<0.005) and in high-grade compared to moderate- and 
low-grade samples [0.6±0.5 (G2-4) ADU vs. 2.1±1.4 (G5-7) 
ADU and 4.7±0.8 in (G8-10), p<0.001]. Since changes in the 
levels of stromal constituents, such as reduced levels or loss 
of caveolin-1 expression and increased TP (Imgenex, San 
Diego, CA) levels, were associated with PCa-derived cultures 
with high Gleason scores compared to BPH with low Gleason 
scores, we analyzed the expression of these proteins. We 
observed that caveolin-1 (Scbt H96) levels were significantly 
higher in BPH- compared to PCa-derived cultures [3.3±0.5 
ADU for BPH vs. 1.5±0.9 ADU, respectively; p<0.001] and 
in low-grade compared to moderate- and high-grade samples 
[2.6±0.4 (G2-4) ADU vs. 1.2±0.2 (G5-7) ADU and 0.7±0.2 in 
(G8-10); p<0.005]. TP levels were significantly lower in BPH- 
compared to PCa-derived cultures [0.8±0.5 ADU for BPH vs. 
3.5±0.7 ADU, respectively; p<0.001], whereas no statistically 
significant differences were observed for low-, moderate- and 
high-grade PCa-derived cultures [3.3±0.5 (G2-4) ADU vs. 
4.1±0.3 (G5-7) ADU and 3.2±0.8 in (G8-10); not significant].
We then analyzed the secretion of two major stromal 
secreted cytokines (SDF1α and TGF-β) in conditioned media 
harvested from subconfluent BPH- and PCa-derived cultures. 
The results demonstrated that the levels of TGF-β1 and SDF1α 
were significantly higher in PCa-derived cultures (65.0±27.8 pg/
ml for SDF1α and 158±64 pg/ml for TGF-β1) compared to those 
observed in BPH-derived cultures (12±4 pg/ml for SDF1α and 
21±6 pg/ml for TGF-β1; p<0.001 for both cytokines). SDF1α 
and TGF-β1 secretion was higher and with respect to moderate- 
and low-grade samples [SDF1α: 40.3±12.0 (G2-4) ADU 
vs. 56.5±15.3 (G5-7) ADU and 72.7±31.2 (G8-10), p<0.005; 
TGF-β1: 84.6±37.0 (G2-4) ADU vs. 115.3±45.3 (G5-7) ADU 
and 184.8±51.2 (G8-10), p<0.001].
Gelatin and plasminogen-dependent zymography. Fig. 4 
demonstrates that prostatic stromal cell cultures primarily 
secreted MMP-2, whereas MMP-9 secretion was low/absent 
in BPH-derived cultures (Fig. 4A) and restricted in some 
PCa-derived cultures (Fig. 4B; 12/30, 40%). Higher levels of 
the active form of MMP-2 were observed in PCa- compared to 
BPH-derived cultures. 
TIMP1, TIMP2 and TIMP3 were also present in the 
conditioned media. BPH- and PCa-derived cultures (Fig. 4B) 
presented similar levels of TIMP1 (Fig. 4B), whereas the levels 
of TIMP2 were higher in PCa-derived cultures and TIMP3 
was only expressed in BPH-derived cultures. 
Low levels of urokinase plasminogen activator (uPA) and 
absent tissue levels of tissue plasminogen activator (tPA) were 
observed in conditioned media from BPH-derived cultures 
(Fig. 4A), whereas higher levels of uPA (both as high molecular 
Figure 3. Western blot analyses of thymidine phosphorylase (TP), androgen 
receptor (AR), prostate-specific antigen (PSA), caveolin-1, tenascin C and 
p75NTR in primary culture cell extracts harvested from (A) BPH- and 
(B) PCa-derived cultures. Each lane was loaded with 40 µg of total protein.
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weight and low molecular weight isoform) were observed in the 
conditioned media from PCa-derived cultures. tPA activity was 
observed in some (8/30, 26.7%) PCa-derived cultures. High 
levels of pro-MMP-9 and active MMP-2 as well as uPA and 
tPA were obserevd in the cultures with a higher content of MFs.
Discussion
The tumor-associated stroma is not simply a supporting 
element for cancer cells, but plays an important role in tumor 
growth, invasion and metastasis. Prostate stromal cells, and 
the ECM which they deposit, play a key role in restraining 
or promoting tumorigenesis through different mechanisms, 
including increased arachidonate metabolism and inflamma-
tion, promoting local tumor invasion. Eicosanoids modulate 
the interaction of tumor cells with various host components 
in cancer metastasis. Their synthesis involves the release 
of arachidonic acid (AA) from cellular phospholipids by 
phospholipase A2 (PLA2), followed by metabolism by cyclo-
oxygenases and lipooxygenases (25). The specific nature of the 
human PCa stromal phenotype has been shown to be an inde-
pendent clinical prognostic marker (26,27), underlining the 
importance of paracrine interactions in human disease. The 
prostate tumor microenvironment is complex, including cells 
of many different lineages (28-31). These include, but are not 
limited to, smooth muscle, various types of fibroblasts, senes-
cent stromal cells, nerves and blood vessels and a wide variety 
of immune and inflammatory cell types. The diversity in the 
types of cells that compose the tumor stroma makes it difficult 
to study the contribution of each component. In addition, the 
lack of stromal cell lines that can retain the tumor-inducing 
properties shown by cancer-associated fibroblasts (CAFs) 
in vivo represents another important issue.
The results of the present study show differences in the 
percentage of stromal cell populations harvested from BPH 
and PCa primary stromal cultures. The two predominant cell 
types in the stroma of the prostate, are SMCs and fibroblasts. 
Fibroblasts represent the major stromal cell type, and a higher 
percentage of MFs are harvested from PCa. MFs are important 
components of the prostatic stroma. The mutual interaction 
through direct cell-cell contacts or paracrine signals between 
cancer cells and MFs is essential for invasive growth and is 
translated into a poor clinical prognosis. Tumor progression is 
deeply influenced by epigenetic changes induced by the tumor 
stroma. Reduced levels or loss of caveolin-1 expression and 
increased TP were observed in PCa-derived cultures with high 
Gleason scores compared to those observed in BPH-derived 
cultures with low Gleason scores. Caveolin-1 was strongly 
associated with the presence of fibroblasts. Although it 
has been demonstrated that the fibroblast expression of 
caveolin-1 favors directional migration and invasiveness of 
carcinoma cells in vitro as well as in vivo, stromal caveolin-1 
remodels peri- and intratumoral microenvironments to 
facilitate tumor invasion, correlating with increased metastatic 
potency (32,33), current evidence indicates that the increased 
expression of caveolin-1 in prostate adenocarcinoma cells and 
the downregulation of the protein in prostate stroma, mediate 
progression to the castration-resistant phase of PCa (34). 
CAFs have been reported to promote epithelial-mesenchymal 
transition in cancer cells, thereby enhancing their aggres-
siveness and stem-like properties (7,35-38). We observed 
that PC3 xenograft-derived murine CAFs were enriched in 
caveolin-1-positive cells, suggesting that expeirmental in vivo 
models may be similar. The presence of a reactive stromal 
phenotype in PCa-derived stromal cells is associated with the 
retention of AR and p75NTR expression, TGF-β1, MMP-9 
and VEGF secretion, as well as the overexpression of the 
chemokine, SDF1α/CXCL12. This phenotypic appearance can 
support the proliferation and invasion of PCa cell lines, such 
as PC3 and 22rv1. MF cultures secreted higher levels of active 
MMP-2 both in the pro-enzyme and active form. MMP-2 is a 
well-known MMP related to cancer cell invasion and metas-
tasis; its overexpression can be induced by cytokines, growth 
factors and oncogenes (36-38). Some cultures of PCa-derived 
sromal cells express MMP-9 as a pro-enzyme (37-39). This 
in vitro study contributes to a better understanding of the cell 
composition of the reactive stromal compartment in PCa. The 
isolation of CAFs from aggressive or non-aggressive PCa cell 
xenografts may represent tool for the study of stroma-tumor 
cell interactions.
Figure 4. Gelatinolytic activity (MMP-9 and MMP-2) of tissue inhibitors of 
metalloproteinase (TIMP1, TIMP2 and TIMP3) and plasminogen-dependent 
enzymes (tPA and uPA) present in conditioned media harvested after 48 h 
of subconfluent primary stromal culture cell cultures derived from (A) BPH 
and (B) PCa tissue samples. Each lane was loaded with 60 µl of conditioned 
medium. HMW, high molecular weight; LMW, low molecular weight.
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